ALERTS is an approved clinical study that is being conducted at 100 clinical sites throughout the United States. ALERTS is designed to evaluate the effectiveness of the AngelMed Guardian system, an investigational device.
Check the ALERTS Site Map for the locations of the ALERTS clinical study sites.
The AngelMed Guardian system contains an implantable device, designed to monitor your heart and alert you if it detects conditions that may indicate the onset of a heart attack. There are presently over 500 implanted Guardian devices throughout the world.
This survey takes less than a minute to complete and will let you know if you are a potential candidate for this study. At the end of the survey, you will be given the opportunity to request additional information. Note that we do not collect information about you unless you want us to.